Interpreting blood results (TGN, IGRA, TNF levels abnormal LFT, importance of TDM) 12th N-ECCO Network Meeting 2018
1
NO002: The quality of care questionnaire – development of a valid measure for persons with Inflammatory Bowel Disease12th N-ECCO Network Meeting 2018
1
NO003: Increasing research capacity of IBD nurses across Europe – a case study of Inflammatory Bowel Disease Fatigue (IBD-F) scale translation and validation12th N-ECCO Network Meeting 2018
1
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomicsECCO'18 Vienna 2018
1
OP006: Apremilast for active Ulcerative Colitis: A phase 2, randomised, double-blind, placebo-controlled induction studyECCO'18 Vienna 2018
1
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative ColitisECCO'18 Vienna 2018
1
OP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.ECCO'18 Vienna 2018
1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative ColitisECCO'18 Vienna 2018
1
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's DiseaseECCO'18 Vienna 2018
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for Inflammatory Bowel Disease and irritable bowel syndromeECCO'18 Vienna 2018
1